Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.246, 2000-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Celecoxib: a model therapy for RA and OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
Access to resources
Recommend
Lubiprostone brings relief in IBS with constipation
Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. :
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Celecoxib and rofecoxib equally effective in knee OA
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :